XML 35 R12.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Intangibles, Net and Goodwill | 6 Months Ended
--- | ---
Jun. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract] |
Intangibles, Net and Goodwill | 6. Intangibles, Net and Goodwill Intangibles, Net Finite-lived Intangible Assets As of June 30, 2024, the Company's finite-lived intangible assets consisted of acquired ARIKAYCE R&D and the milestones paid to PARI for the license to use the Lamira® Nebulizer System (Lamira) for the delivery of ARIKAYCE to patients as a result of the US Food and Drug Administration (FDA) and EC approvals of ARIKAYCE in September 2018 and October 2020, respectively. The Company began amortizing its acquired ARIKAYCE R&D and PARI milestone-related intangible assets in October 2018, over ARIKAYCE's initial regulatory exclusivity period of 12 years. Amortization of these assets during each of the next five years is estimated to be approximately $5.1 million per year. Indefinite-lived Intangible Assets As of June 30, 2024, the Company's indefinite-lived intangible assets consisted of acquired IPR&D from the Business Acquisition (see Note 16 - Acquisitions). Indefinite-lived intangible assets are not amortized. A rollforward of the Company's intangible assets for the six months ended June 30, 2024 and June 30, 2023 is as follows (in thousands):
Intangible Asset |  | December 31, 2023 |  | Additions |  | Amortization |  | June 30, 2024
Acquired ARIKAYCE R&D |  | $ | 32,738 |  |  | $ | — |  |  | $ | (2,425) |  |  | $ | 30,313 |
Acquired IPR&D |  | 29,600 |  |  | — |  |  | — |  |  | 29,600 |
PARI milestones |  | 1,366 |  |  | — |  |  | (101) |  |  | 1,265 |
|  | $ | 63,704 |  |  | $ | — |  |  | $ | (2,526) |  |  | $ | 61,178 |
Intangible Asset |  | December 31, 2022 |  | Additions |  | Amortization |  | June 30, 2023
Acquired ARIKAYCE R&D |  | $ | 37,588 |  |  | $ | — |  |  | $ | (2,425) |  |  | $ | 35,163 |
Acquired IPR&D |  | 29,600 |  |  | — |  |  | — |  |  | 29,600 |
PARI milestones |  | 1,568 |  |  | — |  |  | (101) |  |  | 1,467 |
|  | $ | 68,756 |  |  | $ | — |  |  | $ | (2,526) |  |  | $ | 66,230 |
Goodwill The Company's goodwill balance of $136.1 million as of June 30, 2024 and December 31, 2023, resulted from the August 2021 Business Acquisition. See Note 16 - Acquisitions for further details.

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for all or part of the information related to intangible assets. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/350-30/tableOfContent Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482665/350-30-50-4 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 985 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 985 -SubTopic 20 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/985-20/tableOfContent + Details
Name: | us-gaap_IntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration